Peggy S Sullivan

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development
    Peggy S Sullivan
    Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095 1732, USA
    Mod Pathol 25:1140-8. 2012
  2. ncbi Classical pathology versus molecular pathology in renal cell carcinoma
    Peggy Soung Sullivan
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, 10833 Le Conte Avenue, CHS A7 149, Los Angeles, CA 90095, USA
    Curr Urol Rep 8:5-11. 2007
  3. ncbi Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Peggy S Sullivan
    Department of Pathology and Laboratory Medicine, David E Geffen School of Medicine, Los Angeles, California 90095, USA
    Breast J 15:146-54. 2009
  4. ncbi Accurate classification of sentinel lymph node metastases in patients with lobular breast carcinoma
    Sophia K Apple
    UCLA Path and Lab Med, University of California Los Angeles, CA 90095 1732, USA
    Breast 19:360-4. 2010

Collaborators

Detail Information

Publications4

  1. ncbi Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development
    Peggy S Sullivan
    Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095 1732, USA
    Mod Pathol 25:1140-8. 2012
    ..TTF-1 expression in normal endometrium could potentially provide clinically useful information as a biomarker for the risk of endometrial cancer...
  2. ncbi Classical pathology versus molecular pathology in renal cell carcinoma
    Peggy Soung Sullivan
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, 10833 Le Conte Avenue, CHS A7 149, Los Angeles, CA 90095, USA
    Curr Urol Rep 8:5-11. 2007
    ....
  3. ncbi Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Peggy S Sullivan
    Department of Pathology and Laboratory Medicine, David E Geffen School of Medicine, Los Angeles, California 90095, USA
    Breast J 15:146-54. 2009
    ..Lobular carcinomas respond poorly to neoadjuvant chemotherapy as evidence by lack of complete pathologic response and rare histologic tissue response...
  4. ncbi Accurate classification of sentinel lymph node metastases in patients with lobular breast carcinoma
    Sophia K Apple
    UCLA Path and Lab Med, University of California Los Angeles, CA 90095 1732, USA
    Breast 19:360-4. 2010
    ..The criteria for assessing small volume metastases in the sentinel lymph node of patients with invasive lobular carcinoma need to be more clearly defined...